Search
01/08/2025
Efficacy and safety of mechanical thrombectomy in acute ischaemic stroke secondary to infective endocarditis
Lapeña, P, Urra, X, Llopis, J, Hernández-Meneses, M, Cuervo, G, Maisterra, O, Escrihuela-Vidal, F, Prats-Sánchez, L, Sáez, C, Olmos, C, Hernández-Fernández, F, Werner, M, de la Ossa, NP, Quintana, E, Moreno, A, Chamorro, A, Miró, JM. Efficacy and safety of mechanical thrombectomy in acute ischaemic stroke secondary to infective endocarditis. CLINICAL MICROBIOLOGY AND INFECTION. 2025; 31(8)DOI:10.1016/j.cmi.2025.02.008. PMID:39924109. IF:8.500(Q1/1D).
01/08/2025
Switching Enzyme Replacement Therapy for Late-Onset Pompe Disease From Alglucosidase Alfa to Cipaglucosidase Alfa Plus Miglustat: Post Hoc Effect Size Analysis of PROPEL
Kushlaf, H, Díaz-Manera, J, Bratkovic, D, Byrne, BJ, Claeys, KG, Clemens, PR, Dimachkie, MM, Kishnani, PS, Laforêt, P, Roberts, M, Schoser, B, Toscano, A, Castelli, J, Holdbrook, F, Das, SS, Goldman, M, Mozaffar, T. Switching Enzyme Replacement Therapy for Late-Onset Pompe Disease From Alglucosidase Alfa to Cipaglucosidase Alfa Plus Miglustat: Post Hoc Effect Size Analysis of PROPEL. MUSCLE & NERVE. 2025; 72(2)DOI:10.1002/mus.28420. PMID:40342075. IF:3.100(Q2/4D).
01/08/2025
CSF Biomarker-Based Cognitive Trajectories in Parkinson's Disease-Subjective Cognitive Decline
Rodriguez-Antiguedad, J, Puig-Davi, A, Ruíz-Barrio, I, Pagonabarraga, J, Vázquez-Oliver, A, Horta-Barba, A, Kulisevsky, J, Martínez-Horta, S. CSF Biomarker-Based Cognitive Trajectories in Parkinson's Disease-Subjective Cognitive Decline. Annals of Clinical and Translational Neurology. 2025; 12(8)DOI:10.1002/acn3.70075. PMID:40501082. IF:3.900(Q1/3D).
01/08/2025
Targeting hallucinations in schizophrenia: Improving research translation into clinical practice
Corripio, I, Roldán, A. Targeting hallucinations in schizophrenia: Improving research translation into clinical practice. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2025; 97DOI:10.1016/j.euroneuro.2025.05.005. PMID:40409235. IF:6.700(Q1/1D).
01/08/2025
Low type-2 immune effectors modulate atopic diseases' protective role in pancreatic cancer risk
He, JC, Alhamwe, BA, Sabroso, S, Carrato, A, Hidalgo, M, Molero, X, Iglesias, M, Perea, J, Farré, A, Tardón, A, Dominguez-Muñoz, E, Barberà, V, Muñoz-Bellvís, L, Löhr, M, Greenhalf, W, O'Rorke, M, Gress, T, Crnogorac-Jurcevic, T, Gayà, A, Langtry, A, Kleeff, J, Lawlor, R, Real, FX, Renz, H, Malats, N, PanGenEU Study Investigators. Low type-2 immune effectors modulate atopic diseases' protective role in pancreatic cancer risk. INTERNATIONAL JOURNAL OF CANCER. 2025; 157(3)DOI:10.1002/ijc.35397. PMID:40098454. IF:4.700(Q1/3D).
01/08/2025
Impaired cerebrospinal fluid lipoprotein-mediated cholesterol transport in Alzheimer's disease
Querol, CB, Canyelles, M, Santos, D, Martínez, J, Mercer, A, Zhao, Q, Rotllan, N, Núñez, E, Vázquez, J, Maspoch, D, Cano-Sarabia, M, Carmona-Iragui, M, Sirisi, S, Lleó, A, Fortea, J, Alcolea, D, Blanco-Vaca, F, Escolà-Gil, JC, Tondo, M. Impaired cerebrospinal fluid lipoprotein-mediated cholesterol transport in Alzheimer's disease. ATHEROSCLEROSIS. 2025; 407DOI:. PMID:. IF:5.700(Q1/1D).